City Light is a venture capital firm that invests early in impactful companies. They partner with experienced teams building category-defining solutions in the areas of education, safety and care, and the environment - where more revenue equals better lives at scale, every time. As one of the earliest and most successful impacts investing firms, City Light has a track record of identifying and scaling impact in ways that build better companies.  The firm was founded in 2004 and is based in New York, New York. Some of its key portfolio investments are 2U (Nasdaq: TWOU), ShotSpotter (Nasdaq: SSTI), Trilogy Education, and Ready Responders.

City Light Capital

Vast Ventures they invest in consumer brands, AI and cloud software, and more.

Vast Ventures

humbition is an early-stage operators fund investing in mission-driven companies and the innovative entrepreneurs who founded them. Key areas of investment include marketplaces, consumer and health tech. Founded in 2017 by Cyrus Massoumi, founder of Zocdoc, Indiegogo founder Slava Rubin and COO Frederik Roikjer, the fund recently announced $30 million in total capital. humbition has invested in four portfolio companies, including online furniture startup Burrow and three others currently in stealth mode. The fund’s impressive roster of advisers includes founders from Compass, Warby Parker, ClassPass, Casper and many more.

humbition

Company Ventures is an early-stage venture firm that facilitates interactions between peers and delivering a dynamic shared experience. The firm helps businesses of all sizes unlock true value. It was founded in 2018 and headquartered in New York, United States.

Company Ventures

Atento Capital is a Tulsa-based investment firm focused on returns, quality job creation, and being helpful.  They look for exceptional entrepreneurs that address large markets. Most of their investments will be in early-stage venture funds from other parts of the country and world. They look for funds with cumulative advantages in their investment space that can drive outsized returns, but also those who will be willing partners in their effort to build a tech ecosystem in the city of Tulsa.

Atento Capital

Lafayette Square is a commercially scaled investment platform built for impact and underpinned by technology.

Lafayette Square

RareBreed Ventures is a pre-seed fund that invests in technology companies. It allows angel investors to become limited partners for larger funds down the line. RareBreed was founded in 2021 by McKeever ''Mac'' Conwell.

RareBreed Ventures

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the Regional Economic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

New York Ventures

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital to date.  The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Gaingels

TXV Partners is a seed and Series A firm headquartered in Austin with an office in San Francisco. We invest in technologies that will change the way that we live, work, and play.  People-centered. Diverse perspectives. Insightful capital.

TXV Partners

NEXT VENTŪRES is a venture capital firm that invests in the sports, fitness, health, and wellness markets. With established expertise and deep connections in these markets as well as proven financial track records, the NEXT VENTŪRES team is well positioned to create significant value for their investors and their portfolio companies. The firm was established in 2018 and is based in San Francisco, CA

NEXT VENTŪRES

Serena Ventures focuses on early-stage companies and giving them the opportunity to be heard. Serena Ventures extends relationships, encourages collaboration among portfolio companies, and expands partnership opportunities across my vast network.

Serena Ventures

Genius Guild is a business creation platform that supports market-driven innovations to end racism. Using a venture studio model, it invests in Black entrepreneurs building scalable businesses that serve black communities and beyond. The company applies an investment lens that actively addresses the ways in which capitalism and capitalist markets have been manipulated to limit, exclude, and defraud black communities, creating 360 value for communities, investors, and entrepreneurs. Genius Guild was founded by Kathryn Finney, one of Inc. Magazine's ''Most Influential Women in Tech'' and the visionary founder of The Doonie Fund, The Budget Fashionista, and digitalundivided and is headquartered in Atlanta, Georgia.

Genius Guild

Juno Medical

Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.

<div><p>New York-based Juno Medical provides both in-person and virtual healthcare services, including primary care, pediatrics, women&rsquo;s health, and same-day care. Patients are also able to consult care team members via Juno&rsquo;s patient portal &ldquo;Onpatient.&rdquo; The company operates both on a pay-per-visit basis as well as a subscription basis while accepting most health plans. Its subscription plans include both individual and family rates (USD 20 and USD 50 respectively), with subscribers getting access to savings with other local establishments and access to community events.</p></div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div>
  <p>
    New York-based Juno Medical provides both in-person and virtual healthcare services, including primary care, pediatrics, women&rsquo;s health, and same-day care. Patients are also able to consult care team members via Juno&rsquo;s patient portal &ldquo;Onpatient.&rdquo; The company operates both on a pay-per-visit basis as well as a subscription basis while accepting most health plans. Its subscription plans include both individual and family rates (USD 20 and USD 50 respectively), with subscribers getting access to savings with other local establishments and access to community events.
  </p>
  <p>
  </p>
  <p>
    <b>Funding and financials</b>
  </p>
  <p>
    In December 2022, the company raised USD 12 million in a Series A funding round co-led by Julian Eison, managing partner at NEXT VENTURES, and professional tennis player Serena Williams, managing partner at Serena Ventures, along with participation from other venture capital firms. The raised funds were set aside to increase the geographical footprint of Juno&rsquo;s clinics into three new cities; Atlanta, Tulsa, and Los Angeles. The funding was also earmarked&nbsp; to develop the company&rsquo;s online patient platform further.
  </p>
</div>


<div>
  <p>
    Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
  </p>
  <p>
    In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
  </p>
  <p>
  </p>
</div>


Nice Healthcare

<div>
  <p>
    Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications. 
  </p>
  <p>
    Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.
  </p>
</div>


Amicomed

<div>
  <p>
    Winston is a men&rsquo;s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients. 
  </p>
  <p>
    The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.
  </p>
</div>


Winston

<div>
  <p>
    Eko Health is a cardiopulmonary digital health company that aims to improve heart and lung care for patients using sensors and artificial intelligence. The company produces connected handheld digital stethoscopes with electrocardiogram functionality to detect heart rhythm abnormalities using artificial intelligence (AI) algorithms. In 2020, the company obtained 501(k) FDA clearance for multiple algorithms that help detect heart murmurs and atrial fibrillation, or AFib. These algorithms were used in 2022 to develop the Eko App, which pairs to the company's stethoscopes for report generation, information sharing and carrying out examinations. 
  </p>
  <p>
    The company operates on a fee per unit B2B2C model and a D2C model, where it provides its technology to medical practitioners or patients for diagnostic purposes.
  </p>
  <p>
    In February 2023, Eko 
    <a href="https://sp-edge.com/updates/16677">
      launched SENSORA
    </a>
    , a cardiac disease detection platform that combines the company&rsquo;s existing digital stethoscopes with a machine learning-based platform. The platform enables primary care physicians to detect structural murmurs and assess heart arrhythmias by using a database of heart sounds to compare and identify anomalies in a patient's heart beat. 
  </p>
  <p>
    In April 2024, Eko 
    <a href="https://sp-edge.com/updates/28111">
      obtained FDA 510(k) clearance
    </a>
     for its AI-aided cardiac tool, Eko Low Ejection Fraction Tool (ELEFT). The tool is designed to assist providers in early detection of low ejection fraction, a significant sign of heart failure.
  </p>
  <p>
    <b>Funding and financials</b>
  </p>
  <p>
    In March 2022, raised a further USD 30 million in an extension to its Series C round, which began November 2020. The total funds raised by the company stood at USD 126 million as of March. These funds have been allocated to support further commercialization efforts and develop new products for the company.
  </p>
  <p>
  </p>
  <p>
  </p>
  <p>
  </p>
</div>


<div>
  <p>
    Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
  </p>
  <p>
    The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care,  wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
  </p>
  <p>
    <b>Key Customers and partnerships</b>
  </p>
  <p>
    Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
  </p>
  <p>
    <b>Fundings and financials</b>
  </p>
  <p>
    As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
  </p>
  <p>
    In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
    an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
     
    Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
    <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
      <u>acquired by financial services company Sun Life Financial</u>
    </a>
     for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
  </p>
  <p>
  </p>
</div>


Dialogue

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Juno Medical

Telehealth

Key stats

Recent Updates

Juno Medical raises USD 12 million in Series A funding

Juno Medical raises USD 5.4 million in seed funding

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless